This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Abercrombie Revamps its Corporate Structure

NEW YORK (The Deal) -- Abercrombie & Fitch(ANF - Get Report) the teen apparel retailer, said on Tuesday, Jan. 28, that it would split the offices of chairman and chief executive, as well as eliminate its poison pill.

Despite an executive management team that historically has been entrenched, the retailer is now bowing to activist pressure, say industry bankers. "The activists are winning," a banker said.

The company has also added three new members to its board of directors, including Arthur Martinez, Terry Burman, and Charles Perrin. Martinez will serve as the new chairman.

The moves institute oversight of management by the board and could even set the stage for a search for a new CEO, one banker said. It is also part of a broader corporate trend, in which the CEO and chairman positions are being separated at a number of companies to improve governance ratings.

But at Abercrombie, the personnel changes could also diminish CEO Michael Jeffries role, who has been opposed to a sale of the company.

Still, one industry banker cautioned that getting rid of a poison pill is sometimes only a symbolic gesture, as a shareholder rights plan can be re-instituted in seconds.

That was the tack that activist investor Engaged Capital LLC took when it responded to the company's latest actions.

"We are pleased to see the Board respond to our stated concerns at Abercrombie by enacting the earlier announced governance changes," Engaged chief investment officer and founder Glenn Welling said in a statement. "While a good first step, we believe these reactive changes alone will not be sufficient to put the company back on a course towards creating shareholder value.

"It is imperative that the board, independent of management, objectively evaluate value-maximizing strategic and organizational changes at all times, and not just when convenient to placate shareholders," Welling added.

Last year, Engaged urged the the board not to renew Jeffries contract when it came up for renewal next month. But the board responded by extending Jeffries' contract for two years.

With teens no longer willing to pony up for expensive logo laden T-shirts, the company has seen its fortunes decline in recent months.

In previous quarters, Abercrombie was clocking double-digit comparable store sales declines. In the fiscal third quarter alone that ended Nov. 2, comparables were down 14%, for example. Its stock price as well has gone into decline; it is currently trading at a 60-day moving average of $34.38 per share, as opposed to last summer when it was trading in the high $40s.

Yet, despite improving numbers, the board appears to be warming up to the prospect of a sale.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
ANF $20.76 0.00%
AAPL $131.39 0.00%
FB $80.48 0.00%
GOOG $542.51 0.00%
TSLA $245.62 0.00%

Markets

DOW 18,285.74 +0.34 0.00%
S&P 500 2,130.82 +4.97 0.23%
NASDAQ 5,090.7940 +19.0510 0.38%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs